Bristol-Myers Squibb Co
CELG_r0.025
-0.014-37.09%
收盤 05/19, 16:00（美東）報價延遲15分鐘
--總市值
--本益比TTM
關於 Bristol-Myers Squibb Co 公司
百時美施貴寶公司是一家生物製藥公司，致力於發現、開發和提供先進藥物，幫助患者戰勝嚴重疾病。該公司提供各種治療類別的產品，包括腫瘤學、血液學、免疫學、心血管和神經科學。其醫藥產品包括化學合成或小分子藥物、通過生物過程產生的產品（稱爲生物製劑）和嵌合抗原受體 (CAR-T) 細胞療法。小分子藥物通常以片劑或膠囊的形式口服，但也使用其他藥物輸送機制。生物製劑通過注射或靜脈輸液給患者給藥。其在線產品包括 Eliquis、Opdivo、Orencia、Pomalyst/Imnovid、Yervoy、Sprycel、Reblozyl、Opdualag、Abecma、Zeposia 等。該公司的產品線包括 Krazati、MRTX1719、RYZ101、KarXT、ORM-6151 和 Repotrectinib。
公司簡介
公司代碼CELG_r
公司名稱Bristol-Myers Squibb Co
上市日期Mar 17, 1980
成立日期1933
CEODr. Christopher S. (Chris) Boerner, Ph.D.
員工數量- -
證券類型- -
年結日- -
公司地址Route 206 And Province Line Road
城市PRINCETON
上市交易所- -
國家United States of America
郵編08543
電話16092524621
網址https://www.bms.com
公司代碼CELG_r
上市日期Mar 17, 1980
成立日期1933
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael R. (Mike) Mcmullen
Mr. Michael R. (Mike) Mcmullen
Independent Director
Independent Director
--
--
Mr. Benjamin Hickey
Mr. Benjamin Hickey
President - RayzeBio Organization, Member of the Leadership Team
President - RayzeBio Organization, Member of the Leadership Team
--
--
Dr. Julia A. Haller, M.D.
Dr. Julia A. Haller, M.D.
Independent Director
Independent Director
--
--
Ms. Lynelle Hoch
Ms. Lynelle Hoch
President, Cell Therapy Organization, Member of the Leadership Team
President, Cell Therapy Organization, Member of the Leadership Team
--
--
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
--
--
Mr. Greg Scott Meyers
Mr. Greg Scott Meyers
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
--
--
Ms. Amanda Poole
Ms. Amanda Poole
Executive Vice President, Chief People Officer, Member of the Leadership Team
Executive Vice President, Chief People Officer, Member of the Leadership Team
--
--
Dr. Manuel Hidalgo Medina, M.D., Ph.D.
Dr. Manuel Hidalgo Medina, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert Plenge, M.D., Ph.D.
Mr. Robert Plenge, M.D., Ph.D.
Executive Vice President, Chief Research Officer, Head of Research, Member of the Leadership Team
Executive Vice President, Chief Research Officer, Head of Research, Member of the Leadership Team
--
--
Mr. Samit Hirawat, M.D.
Mr. Samit Hirawat, M.D.
Executive Vice President, Chief Medical Officer, Head of Development, Member of the Leadership Team
Executive Vice President, Chief Medical Officer, Head of Development, Member of the Leadership Team
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael R. (Mike) Mcmullen
Mr. Michael R. (Mike) Mcmullen
Independent Director
Independent Director
--
--
Mr. Benjamin Hickey
Mr. Benjamin Hickey
President - RayzeBio Organization, Member of the Leadership Team
President - RayzeBio Organization, Member of the Leadership Team
--
--
Dr. Julia A. Haller, M.D.
Dr. Julia A. Haller, M.D.
Independent Director
Independent Director
--
--
Ms. Lynelle Hoch
Ms. Lynelle Hoch
President, Cell Therapy Organization, Member of the Leadership Team
President, Cell Therapy Organization, Member of the Leadership Team
--
--
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
--
--
Mr. Greg Scott Meyers
Mr. Greg Scott Meyers
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
股東統計
佔比
Other
100.00%
持股股東
股東統計
佔比
Other
100.00%
股東類型
股東統計
佔比
Other
100.00%
機構持股
更新時間: 3月3日 週一
更新時間: 3月3日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
32
935.03K
0.00%
+254.91K
2024Q4
32
943.43K
0.00%
+289.58K
2024Q3
31
601.53K
0.00%
-30.97K
2024Q2
30
511.50K
0.00%
+7.21K
2024Q1
32
397.74K
0.00%
-298.70K
2023Q4
30
495.62K
0.00%
-151.97K
2023Q3
30
535.93K
0.00%
-247.50K
2023Q2
31
542.98K
0.00%
-138.59K
2023Q1
34
441.11K
0.00%
-360.09K
2022Q4
39
517.53K
0.00%
-445.11K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
International Assets Investment Management, LLC
175.00
0%
+175.00
--
Jun 30, 2024
Transcend Capital Advisors, LLC
117.78K
0%
--
--
Dec 31, 2024
Davenport Asset Management
83.97K
0%
--
--
Dec 31, 2024
Maven Investment Partners US Ltd.
67.86K
0%
+67.86K
--
Dec 31, 2024
BofA Global Research (US)
51.64K
0%
--
--
Dec 31, 2024
Purkiss Capital Advisors LLC
26.45K
0%
+26.45K
--
Dec 31, 2024
Two Sigma Investments, LP
26.14K
0%
+10.37K
+65.77%
Dec 31, 2024
MainStreet Advisors
20.00K
0%
--
--
Dec 31, 2024
Watts Gwilliam & Co LLC
20.00K
0%
--
--
Dec 31, 2024
Private Advisor Group LLC
15.00K
0%
--
--
Dec 31, 2024
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
